Talking O&G - a RANZCOG Podcast

In this episode of Talking O&G: a RANZCOG Podcast, host Dr Nisha Khot speaks to Associate Professor Alexis Shub about the ADIPS 2025 Consensus Recommendations for the Screening, Diagnosis, and Classification of Gestational Diabetes.  

Gestational diabetes mellitus (GDM) is one of the most common conditions of pregnancy – in 2023, 17% of pregnant people in Australia were diagnosed with GDM. Dr Khot and A/Prof Shub unpack the changes in the ADIPS guideline – including an increased diagnostic threshold for GDM and reduced reliance on early-pregnancy OGTT – and the benefits they carry for both clinicians and patients. They explore the increased focus on the HbA1c test, what the options are for people unable to tolerate an OGTT, and tips for clinicians adopting the guideline into practice.  

While this guideline is specific to Australian practitioners, separate guidelines are currently under development for Aotearoa New Zealand, which will be covered in a future episode of Talking O&G. 

🔗 Resources mentioned in this episode: 

Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes 

ADIPS Frequently Asked Questions 

The Conversation “How pregnant women are tested for gestational diabetes is changing. Here’s what this means for you” 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: A RANZCOG Podcast, host A/Prof Scott White is joined by Professor Lisa Hui and Dr Lilian Downie to unpack RANZCOG’s Clinical Guideline for Prenatal Screening for Fetal Structural Anomalies and Chromosome Conditions (C-Obs 35). This updated guideline combines four previous statements to consolidate recommendations, acknowledging the interrelatedness of genetics and structural anomalies.  

Professor Hui and Dr Downie are expert clinicians who were involved in the development of the new guideline. They discuss non-invasive perinatal testing (NIPT), chorionic villus sampling (CVS), changes in recommendations for structural ultrasounds, equity and access issues, pre- and post-test counselling, and more.  

Professor Hui and Dr Downie emphasise that all pregnant people should be offered prenatal screening, regardless of their demographic or any assumptions about their attitude to screening.  

🔗 Resources mentioned in this episode: 

Screening and diagnosis of fetal structural anomalies and chromosome conditions (C-Obs 35)  

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: A RANZCOG Podcast, host A/Prof Scott White speaks to expert clinicians Dr Heather Waterfall and Dr Shaylee Iles about RANZCOG’s Birth After Caesarean Clinical Guideline (C-Obs 38).  

Rates of caesarean births continue to rise across Australia and Aotearoa New Zealand, with repeat caesarean births being a leading contributing factor. Comprehensive, evidence-based guidance is vital to ensure clinicians feel empowered to counsel patients in making informed decisions for their subsequent births.    

Dr Waterfall is a generalist O&G practising in the Adelaide Hills, and Dr Iles is a director of obstetrics at a tertiary unit in NSW and was Chair of the RANZCOG Guideline Development Group. They discuss some of the key changes presented in the guideline, the implications for clinical practice, how to advise on birth method after caesarean, the use of risk calculators, induction of labour, and more. The conversation emphasises the importance of an individualised approach that champions informed decision-making.  

🔗 Resources mentioned in this episode: 

Birth After Caesarean Clinical Guideline (C-Obs 38)  

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733  

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues. 

RANZCOG acknowledges the need for more inclusive terminology for gender diversity.  

In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.   

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G: A RANZCOG Podcast, hosts Dr Nisha Khot and Dr Heather Waterfall speak to Professor Kirsten Black and Dr Catriona Melville about RANZCOG’s Clinical Guideline for Abortion Care.

This guideline is the first binational evidence-based clinical practice guideline on abortion care for Australia and Aotearoa New Zealand. Both Prof Black and Dr Melville are sexual reproductive health experts who contributed to its development. They discuss key evidence-based recommendations including pre-abortion considerations, telehealth provision, STI screening, medical and surgical techniques, and providing contraception following an abortion.

They also highlight the importance of providing individualised, person-centred care which promotes equity and cultural safety, as well as considerations for those in rural or remote areas. They encourage clinicians to engage in further training opportunities in abortion care where possible, emphasising that equitable abortion access is an essential part of healthcare provision.

🔗 Resources mentioned in this episode:

Clinical Guideline for Abortion Care - RANZCOG

Sexual and Reproductive Health Advanced Training Pathway (ATP)

Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study

Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic 

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. 

In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.  

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

In this episode of Talking O&G, host Dr Heather Waterfall is joined by Associate Professor Mathew Leonardi to answer RANZCOG members’ and trainees’ questions on endometriosis.

An internationally recognised leader in gynaecological surgery and ultrasound, Mathew is an Associate Professor at McMaster University Medical Centre in Hamilton, Canada, and holds a PhD from the University of Sydney. He sits on the World Endometriosis Society Early Career Board and is a founding member of the Next Generation Committee at the International Society of Ultrasound in Obstetrics and Gynaecology.

During the discussion, Mathew weighs in on the shift towards ultrasound as the preferred first-line diagnostic tool for endometriosis, the benefits and limitations of this method, how MRI compares, and recommendations for laparoscopy as a surgical intervention. Mathew also advocates for upskilling both gynaecologists and sonographers in advanced gynaecological ultrasound, the importance of ‘prehab’, and how to support patients with endometrioma who are seeking fertility.

🔗 Resources mentioned in this episode:

Talking O&G E4. Unpacking RANZCOG’s New Endometriosis Guideline

Australian Living Evidence Guideline: Endometriosis

Patient resources: https://ranzcog.edu.au/womens-health/endometriosis/

📌 RANZCOG members can submit CPD at: https://shorturl.at/iq733

💬 If you found this episode valuable, please rate, review, subscribe, and share it with your colleagues.

RANZCOG acknowledges the need for more inclusive terminology for gender diversity. 

In this podcast we aim to use inclusive language, and any use of the term “women” should be interpreted to include all people requiring gynaecological and obstetric care.  

The views expressed are those of the speakers and may not reflect the official position of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).

COI Statement: Mathew Leonardi reports grants from Australian MRFF, AbbVie, AIMA/SOPHIE, CanSAGE, CIHR, Endometriosis Australia, Hamilton Health Sciences, Health Canada, Hyivy/MITACS/SOPHIE, Medical Research Future Fund/Imagendo, Myant Inc/MITACS, GE HealthCare/MITACS, and Pfizer; honoraria for lectures/writing from AIUM, AbbVie, Bayer, Canon, GE Healthcare, Pfizer, Samsung, TerSera; consultancy work with AbbVie, Chugai, Gesynta, Hologic, Imagendo, Pfizer, and Roche Diagnostics; and affiliations with SUGO (Specialized Ultrasound in Gynecology & Obstetrics) and Endometriosis360. He holds leadership roles in the World Endometriosis Society Early Career Board, ISUOG Next Generation, and the Gynecologic Ultrasound Society, all outside the submitted work.